Stock Price Quote

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1485.056.05 (+0.41 %)
PREV CLOSE ( ) 1479.00
OPEN PRICE ( ) 1490.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2450
TODAY'S LOW / HIGH ( )1482.25 1500.00
52 WK LOW / HIGH ( )1046.4 1745
NSE1488.7010.65 (+0.72 %)
PREV CLOSE( ) 1478.05
OPEN PRICE ( ) 1486.00
BID PRICE (QTY) 1488.70 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 120079
TODAY'S LOW / HIGH( ) 1482.65 1500.00
52 WK LOW / HIGH ( )962.65 1748
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924
Management Info
R S Karnad - Chairman S Venkatesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

01Jul GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that the in terms of the pr..
21May GlaxoSmithKline Pharmaceuticals to dis
GlaxoSmithKline Pharmaceuticals has decided to discontinue the manufactu..
21May GlaxoSmithKline Pharmaceuticals gains
GlaxoSmithKline Pharmaceuticals is currently trading at Rs. 1376.45, up..
18May Change in Directorate
Inter alia, the Board has approved the following: 1. Dividend The Bo..
08Apr Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed that in compliance with Reg..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit1109.61100.5
Gross Profit 1492.9 3225
Operating Profit 1721.47360.1
Net Sales 6486.532246.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4667.60 (6.04%)
M.Cap ( in Cr)7747.93
Valiant Organics (BSE)
peergroup  2610.70 (9.39%)
M.Cap ( in Cr)3171.80
Aarti Drugs (BSE)
peergroup  2353.60 (5.68%)
M.Cap ( in Cr)5483.89
Alkem Laboratories (BSE)
peergroup  2980.30 (4.06%)
M.Cap ( in Cr)35633.96
Abbott India (BSE)
peergroup  16188.60 (0.29%)
M.Cap ( in Cr)34399.65

Shareholding Pattern

PROMOTERS 75%
FI/BANKS/INSURANCE 6.78%
MUTUAL FUNDS/UTI 4.81%
NON-INSTITUTION 12.66%
FII 0%
GOVERNMENT 0%

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1485.05. Its current market capitalisation stands at Rs 25157.64 Cr. In the latest quarter, company has reported Gross Sales of Rs. 32243.81 Cr and Total Income of Rs.33033.93 Cr. The company's management includes S Maheshwari, S Williams, P Thakur, D Sundaram, A N Roy, R Krishnaswamy, N Kaviratne ( C B E ), PV Bhide, S Venkatesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)